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HIV infections are still a very serious concern for public heath worldwide. We have applied molecular 
evolution methods to study the HIV-1 epidemics in the Comunidad Valenciana (CV, Spain) from a public 
health surveillance perspective. For this, we analysed 1804 HIV-1 sequences comprising protease and 
reverse transcriptase (PR/RT) coding regions, sampled between 2004 and 2014. These sequences were 
subtyped and subjected to phylogenetic analyses in order to detect transmission clusters. In addition, 
univariate and multinomial comparisons were performed to detect epidemiological differences between 
HIV-1 subtypes, and risk groups. The HIV epidemic in the CV is dominated by subtype B infections 
among local men who have sex with men (MSM). 270 transmission clusters were identified (>57% of 
the dataset), 12 of which included ≥10 patients; 11 of subtype B (9 affecting MSMs) and one (n = 21) 
of CRF14, affecting predominately intravenous drug users (IDUs). Dated phylogenies revealed these 
large clusters to have originated from the mid-80s to the early 00 s. Subtype B is more likely to form 
transmission clusters than non-B variants and MSMs to cluster than other risk groups. Multinomial 
analyses revealed an association between non-B variants, which are not established in the local 
population yet, and different foreign groups.
Of the four phylogenetic groups which comprise HIV-1 (M, N, O, P), group M is the causal agent of the AIDS 
pandemic1, 2. The latest UNAIDS/WHO report3 estimated in almost 37 million the number of persons infected 
with HIV globally, with approximately 2.1 million new infections in 2015.
Although the rate of new HIV diagnosis has stabilized from the early 2000s in the European Union and 
European Economic Area (EU/EEA), transmissions among men who have sex with men (MSM) have experi-
enced a sustained increase, thus following a different trend to other risk groups4. This is evident in Spain: during 
the late 90 s, most HIV new diagnoses were associated to intravenous drug use (IDU). However, in 2013, 51% 
of the infections occurred among MSM5, 6. The increasing incidence among MSM is remarkably high in the age 
range 20–35 years6. HIV infections in Spain also affect the foreign population disproportionally: in 2012, 35% of 
the new diagnosis corresponded to immigrants or persons of foreign origin6.
There exist nine subtypes (denoted as A, B, C, D, F, G, H, J and K) and at least 61 circulating recombinant 
forms (CRFs) within HIV-1 group M7. There are differences among HIV-1 variants in several biological features. 
For instance, some subtypes and CRFs are associated to a faster progression to AIDS than others8, 9. Genetic and 
antigenic differences among HIV-1 subtypes and CRFs are also a challenge for the development of an effective 
HIV-1 vaccine10.
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Worldwide, the most prevalent HIV-1 subtype is C, accounting for around 50% of all cases. However, the 
HIV epidemic in Europe, particularly among MSM, is mainly driven by subtype B11, with frequent reported 
transmission clusters affecting this group12–20. However, there is evidence for an increased introduction of non-B 
subtypes11. For instance, in a sample of 206 patients from Spain, Abecasis and colleagues11 found that CRF02_AG 
was the second most prevalent HIV-1 variant after subtype B (prevalence <2%).
The Comunidad Valenciana (CV) is the fourth largest region in Spain (~5 million inhabitants), representing 
>10% of the total population. Genotypic tests of resistance to antiviral drugs are performed routinely for the 
design of individualized antiretroviral treatments. Here, we have analysed more than 1,800 HIV-1 pol sequences 
obtained between 2004 and 2014 from different patients in the CV. We have used molecular phylogenetic anal-
yses to complement HIV surveillance tasks of the Public Health Directorate of the CV Regional Government. 
Specifically, we have used this information to infer the distribution of HIV-1 subtypes, to analyse the introduc-
tions (and further local expansion) of this virus in the CV, to identify the emergence of new viral variants in this 
region, and also to analyse which risk groups are currently more vulnerable to HIV infection. The results obtained 
from this work may be useful in establishing and reinforcing preventive measures in specific target groups.
Results
Of the 1804 sequences analysed, 1512 (83.8%) belonged to subtype B. Among the 292 non-B sequences, the 
most prevalent HIV-1 variant was CRF02_AG (n = 66, overall prevalence = 3.7%), followed by subtypes A1, F1 
(both n = 34, 1.9%), CRF14_BG (n = 28, 1.6%) and subtype G (n = 20, 1.1%). Other variants (n = 110) were 
present with a prevalence lower than 1.0%. Considering those patients for whom epidemiological information 
was available, 83.04% (930/1120) were male vs 16.96% (190/1120) female; 67.12% (637/949) were native from 
Spain (determined by place of birth) vs 32.87% (312/949) immigrants or of foreign origin; 66.84% (637/953) were 
MSM, 21.41% (204/953) heterosexual (HT) and 11.54% (110/953) IDUs. One patient was infected vertically and 
other one was haemophiliac. The mean age was 34.82 years (range 0 to 76) (Table 1). MSMs were more likely to 
be Spaniards than non-MSM (Fisher’s Exact test, FET: p-value = 5.5 × 10−5, odds-ratio, OR = 1.84 (1.35–2.48).
Phylogenetic analyses revealed the existence of 270 transmission clusters, with sizes ranging from 2 to 111 
patients (Fig. 1A). In total, 1039 patients from the dataset were included in a transmission cluster (57.5%), with 
302 patients (16.7%) included in large clusters of 10 or more patients (Table 1; Fig. 1A). Among the 892 patients 
clustering in transmission groups of subtype B, 407 (45.6%) were MSM, 56 (6.3%) HTs, 38 (4.2%) IDUs and 391 
(43.8%) of unknown transmission route. On the other hand, of the 147 patients clustering in non-B clusters 29 














Male 818 10 13 5 24 11 49 930
Female 115 6 6 8 25 6 24 190
UNK 579 18 15 7 17 11 37 684
Geographical origin
Spain 579 6 5 3 11 8 25 637
W. Europe and N. 
America 27 0 0 0 1 0 1 29
Eastern Europe 17 6 5 0 0 5 6 39
Africa and M. East 13 3 3 10 26 0 12 67
Latin America 141 1 3 0 7 3 19 174
Others 1 0 0 0 0 0 2 3
UNK 734 18 18 7 21 12 45 855
Risk group
HT 124 8 6 9 29 2 26 204
MSM 586 3 6 0 11 1 30 637
IDU 85 3 0 2 3 12 5 110
Other 2 0 0 0 0 0 0 2
UNK 715 20 22 9 23 13 49 851
Clustering
No cluster 622 22 24 13 32 5 49 767
Small cluster (2–3) 371 12 5 7 25 2 39 461
Medium cluster 
(4–9) 240 0 5 0 9 0 22 276
Large cluster 












(22–65) 33.2 (0–62) 34.82 (0–76)
Table 1. Distribution of HIV cases in the dataset (n = 1804) classified by viral subtype, gender, nationality, risk 
group, age and clustering status. *The “Others” subset includes 10 subtype C, 1 subtype D, 13 CRF19_cpx, 12 
CRF12_BF, 9 CRF06_cpx, 7 CRF47_BF and 58 other (mostly unassigned) recombinant sequences.
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(19.7%) were HTs, 29 (19.7%) MSM, 15 (10.2%) IDUs and (50.3%) 74 of unknown transmission route (Fig. 1B). 
Among the transmission clusters that could be classified by the most frequent risk of transmission (≥50%) for 
the CV patients included in them, the most prevalent transmission clusters of subtype B were those classified 
as MSM (n = 99/219, 45.2%), followed by IDUs (n = 18/219, 8.2%) and HTs (n = 15/219, 6.8%). However, for 
non-B transmission clusters, those of HTs were the most frequent ones (n = 16/51, 31.4%), followed by MSM 
(n = 14/51, 27.5%) and IDUs (n = 1/51, 2.0%). 87 of the 219 (39.7%) subtype B clusters and 20 of 51 (39.2%) 
non-B clusters could not be classified based on a majority risk of transmission (Fig. 1C). Subtype B sequences 
were more likely to be part of a transmission cluster than non-B sequences (FET: p-value = 0.007, OR = 1.42, 95% 
CI = 1.09–1.84). Also, MSM were more likely to be part of a transmission cluster than other risk groups (FET: 
p-value = 1.68 × 10−4, OR = 1.56, 95% CI = 1.23–1.99).
Twelve large transmission clusters, which included at least 10 patients from the CV (Fig. 2), were detected: 
11 were from subtype B and included a total of 281 patients (Fig. 2A). One cluster of 21 patients corresponded 
to CRF14_BG (Cluster K, Fig. 2B). Patients infected with subtype B were more likely to form large transmission 
clusters than those infected with non-B variants (FET: p-value = 3.4 × 10−7, OR = 2.94, 95% CI = 1.84–4.92). Nine 
Figure 1. (A) Distribution of sizes (log10 scale) of the 270 transmission clusters found in the CV (2004–2014) 
through phylogenetic analysis. Block letters indicate the 12 clusters that were analysed with BEAST. (B) 
Total number of patients for each risk group included in transmission clusters (n = 1039). (C) Number of 
transmission clusters depending on the risk group in which they were classified. *>1/4 patients shared a known 
risk group, but they were not enough to classify the cluster.
www.nature.com/scientificreports/
4Scientific RepoRTs | 7: 11584  | DOI:10.1038/s41598-017-10286-1
of the large clusters were classified as MSM; the other three included mostly IDUs, although in a proportion lower 
than 50% (Table 2). Dated phylogenies of these clusters (Supplementary Figs 1 to 12) revealed that they originated 
between 1984 (cluster G, unclassified transmission route) and 2005 (cluster B, MSM). Only transmission clusters 
that included MSM as the main transmission risk were originated since 2000 (Table 2; Supplementary Figs 1 to 
12). Bagplots (bivariate representations of boxplots21) representing tree height (the time elapsed between tMRCA 
and the sampling date of the last sequence) and evolutionary rate estimates from the posterior distribution of each 
large cluster are shown in Fig. 3. A significant, negative correlation between median tree height and substitution 
rate estimates of these large clusters was obtained (R = −0.70, p-value = 0.013).
Despite most patients infected with subtype B were Spanish natives (579 Spaniards vs 199 foreigners), a 
majority of those infected with non-B variants were foreigners (58 vs 113; FET: p-value < 2.2 × 10−16, OR = 5.66, 
95% CI = 3.91–8.23). This difference was also observed when considering only patients belonging to a transmis-
sion cluster (subtype B: 378 vs 114; non-B: 31 vs 47; FET: p-value = 1.8 × 10−10; OR = 5.01, 95% CI = 2.96–8.57) 
(Supplementary Table S1).
A total of 88 subtype B, and 9 non-B transmission clusters did not include patients of foreign origin. These 
subtype B clusters included 178 Spanish patients and 122 of unknown origin, and the non-B clusters included 
13 Spanish patients and 14 of unknown origin. A total of 49 subtype B, and 7 non-B transmission clusters were 
formed by both Spanish and non-Spanish patients. Altogether, these mixed subtype B clusters included 200 
Spanish, 87 non-Spanish (mostly from Latin America) and 113 of unknown origin, and the mixed non-B clusters 
included 18 Spanish, 10 non-Spanish (mostly from Latin America or Eastern Europe) and 13 of unknown origin. 
All large transmission clusters but one (cluster G, for which there was not information available in 17 of its 19 
patients) presented this characteristic. Finally, a total of 16 subtype B and 25 non-B transmission clusters included 
only patients of foreign origin. These subtype B clusters included 27 foreign patients (mostly from Latin America) 
and 16 of unknown origin, and the non-B clusters included 37 foreign patients (mostly from Africa/Middle East 
and Latin America) and 20 of unknown origin (Supplementary Table S1).
In addition to the patients’ origin, other variables considered for the multinomial analysis presented differ-
ences between subtypes. So, subtype B sequences were disproportionally more present in males compared to 
females (FET: p-value < 2.2 × 10−16, OR = 4.75, 95% CI = 3.29–6.86), in MSM with respect to HTs and IDUs 
(p-value < 2.2 × 10−16, OR = 7.4, 95% CI = 4.87–11.31 and p-value = 2 × 10−5, OR = 3.37, 95% CI = 1.90–5.89, 
respectively), and in IDUs compared to HTs (p-value = 0.0038, OR = 2.19, 95% CI = 1.26–3.88). There were 
also differences between subtypes with respect to age distribution (Kruskal-Wallis test: P = 0.0013, Chi2 = 21.8, 
df = 6), with CRF02_AG patients being significantly younger than B patients (Games-Howell post-hoc test result 
for this comparison: p = 0.001, t = 4.37, df = 58). Given that no significant differences were found between sub-
types in the distribution of collection dates (P > 0.70), this variable was excluded from the multinomial analysis.
Multinomial analyses were performed using a subset of 906 patients for whom there was information for all 
the variables considered: sex, risk group, country of origin, clustering status and age. We considered as baseline the 
most frequent category for each variable (subtype B, Spaniard, male, MSM, age between 21 and 29 years and not 
clustering), and a significant model was obtained (McFadden R2 = 0.32, Chi2 = 421.34, p-value < 2.2 × 10−16)). We 
checked that this subset was representative of the global set (n = 1804) by means of FETs. The p-values obtained 
for all the analysed variants were >0.05, including the distribution of patients from the different cluster-size cat-
egories (no cluster, small cluster, medium cluster and large cluster) that would result if only sequences included 
in the multinomial analysis had been taken into account for cluster detection, (FET: P > 0.10; Supplementary 
Table S2). This dataset was also genetically representative of the whole dataset (Supplementary Fig. S13). The 
Figure 2. Maximum likelihood trees with the 12 largest transmission clusters highlighted in red. (A) Subtype B 
tree (clusters A-J, L). (B) Subtype G and CRF14_BG tree (cluster K).
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multivariate model shows that the chances of being infected with all non-B groups increased in foreign patients, 
coming from Eastern Europe (A1, F1, 14_BG and the pooled, rare, variants), Africa and the Middle East (F1, 
G, 02_AG and the rare variants) and Latin America (rare variants), with all p-values < 0.01, all ORs >3.0. The 
likelihood of being infected with CRF14_BG also increased in patients older than 50 years (p-value = 0.029, 
OR = 36.2, 95% CI = 1.45–904.0), in IDUs (p-value = 9.44 × 10−5, OR = 257, 95% CI = 15.8–4160) and in those 
patients forming large transmission clusters (p-value = 1.6 × 10−4, OR = 36.9, 95% CI = 5.67–240) (Table 3).
Pairwise genetic distances (GD) between individuals from a given transmission cluster ranged between 0.00 
substitutions/site (s/s), in clusters of sizes of 2, 3, 5, 7, 8, 15, 16, 18 and 111 individuals, and 0.073 s/s, in a cluster of 
6 individuals. For most pairwise comparisons, GD was lower than 0.045 s/s, regardless the size of the transmission 
cluster (Fig. 4; Supplementary Table S3).
Discussion
We have studied the HIV epidemic in the Comunidad Valenciana by analysing, with molecular and evolutionary 
tools, 1804 sequences obtained between 2004 and 2014 from different patients. Our results indicate that the HIV 
epidemic in the CV is dominated by HIV-1 subtype B infections among local MSM. However, non-B infections 
represented an important number of cases, with a prevalence higher than 15%, being CRF02_AG the most prev-
alent non-B variant (prevalence = 3.7%), in agreement with previous estimates for Spain11, 22.
Overall, the detection of transmission clusters demonstrates the importance of the domestic spread of HIV-1 
in the CV. Most patients from the whole dataset (>57%) were included in local transmission clusters, of sizes 
ranging from 2 to 111 individuals. Local transmission was especially important among MSM, who were more 
likely to be included in a transmission cluster, as well as for Spanish natives, than other risk groups. Considering 
the 12 largest clusters (size ≥10 patients), this transmission risk was the most frequent in 9 of them. Excluding 
transmission cluster A (MSM, tMRCA = 1984.7), MSM clusters were of more recent origin as estimated using 
Bayesian coalescent analyses, especially clusters B (n = 13), E (n = 18), H (n = 19) and L (n = 111), which orig-
inated after year 2000. Previous analyses in the Spanish regions of Madrid23 and the Basque Country24 detected 
lower proportions of clustering patients (18 and 27% of their analysed sequences, respectively). These results 
suggest that the importance of local transmissions may not be the same in different Spanish regions. In addition, 
they also found evidences for an increased vulnerability to HIV of the Spanish MSM community in recent years. 
A more detailed analysis of cluster L is provided elsewhere25.
Immigrants were disproportionally represented in the dataset (almost 1/3 of the patients were of non-Spanish 
origin), reflecting their higher vulnerability to HIV infection. Multinomial analyses evidenced the significant 
association between all non-B groups analysed and different foreign populations: Eastern Europe (subtypes A1, 
F1, CRf14_BG and the rare variants), Africa and the Middle East (subtypes F1, G, CRF02_AG and rare variants) 
and Latin America (rare variants). These associations were in agreement with the geographical distributions 
of these variants26–28. These results, along with the fact that most non-B patients, either clustering or not, were 
of non-Spanish origin (CRF14_BG was the only exception) suggest that along the analysed time-span non-B 
HIV variants were not well established among Spanish locals in this region. This is exemplified by the fact that 
almost half of the non-B transmission clusters did not include any Spanish patient. Furthermore, non-B patients 
clustered in a significantly lower proportion than patients infected with subtype B, especially when considering 
clusters with at least 10 patients, thus displaying significantly lower local transmission efficiency. Previous molec-
ular epidemiology studies of HIV-1 in Western Europe also reported non-B variants to be associated with the 
migrant population11, mainly affecting HTs. In the Spanish region of Madrid, where non-B variants have been 
found with a prevalence of up to 37%23, more than 70% of non-B sequences were found to belong to non-Spanish 
patients29. Other works in different Western European countries have reported differences in the prevalence of 
Transmission 
cluster n risk group range # R Model tMRCA (95% HPD)#
Substitution rate (95% 
HPD)*
A 10 MSM 2004–2011 (−0.08) EXPO 1984.7 (1971.2–1994.5) 0.0014 (0.0009–0.0021)
B 13 MSM 2007–2013 0.61 BSP 2005.9 (2003.8–2006.9) 0.0043 (0.0016–0.0087)
C 15 UNK/IDU 2004–2014 (−0.18) BSP 1988.0 (1969.0–1999.2) 0.0015 (0.0007–0.0025)
D 16 MSM 2011- 2013 (−0.05) LOG 1994.9 (1982.4–2006.3) 0.0022 (0.0012–0.0034)
E 18 UNK/MSM 2010–2014 0.25 EXPO 2002.2 (1995.9–2006.8) 0.0018 (0.0011–0.0027)
F 18 MSM 2008–2013 0.40 LOG 1999.3 (1989.6–2005.0) 0.0013 (0.0005–0.0023)
G 19 UNK 2004–2013 (−0.05) EXPO 1984.3 (1966.9–1997.0) 0.0011 (0.0006–0.0019)
H 19 MSM 2008–2014 0.58 BSP 2002.1 (1995.9–2006.2) 0.0019 (0.0010. 0.0029)
I 21 MSM 2004–2012 0.58 LOG 1994.6 (1982.2–2001.3) 0.0012 (0.0005–0.0020)
J 21 MSM 2004–2013 0.76 LOG 1999.5 (1993.2–2003.4) 0.0023 (0.0010–0.0045)
K 21 UNK/IDU 2004–2014 0.62 BSP 1990.6 (1979.6–1998.1) 0.0010 (0.0005–0.0016)
L 111 MSM 2006–2014 0.61 EXPO 2001.8 (1998.6–2004.8) 0.0028 (0.0022–0.0035)
Table 2. Size (n, number of patients), risk group, range of sampling dates and root-to-tip vs sampling date 
correlation coefficient for each transmission cluster (R), and estimates of their tMRCAs (median) and 
substitution rates as obtained with BEAST under the best-fitting demographic model (EXPO: exponential 
growth; BSP: Bayesian Skyline Plot; LOG: logarithmic growth). #Time measured in years. *Substitutions per site 
and year.
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non-B variants in the migrant population. Similarly to our results, in countries such as Switzerland (estimated 
prevalence of non-B HIV sequences = 21%30) or the Belgian-Luxemburg population (prevalence >45%11, 31) 
nearly 70% of non-B variants have been associated to patients of migrant origin30, 31. These results contrast with 
those from Portugal, the Western European country where subtype B displays the lowest prevalence11. An study 
in the Portuguese region of Minho (close to the border with Spain) found non-B variants to have a prevalence of 
73%, and only 10% of these sequences belonged to non-Portuguese patients32, thus evidencing that non-B infec-
tions are already established among locals.
Figure 3. Bagplots representing tree height and evolutionary rate estimates, obtained from the posterior 
distribution of the 12 largest transmission clusters detected (A to L).
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Although 11 of the 12 largest transmission clusters were of subtype B, one of the largest clusters found (n = 21, 
median tMRCA = 1990.6) corresponded to the CRF14_BG, and included a high number of IDUs from Spain. 
CRF14 has been associated to a predominance of CXCR4 tropism, which usually leads to faster AIDS onset33, 34. 
Previous phylogeographic analyses have suggested that CRF14_BG originated in the Iberian Peninsula33, and its 
prevalence is increasing in some Eastern European countries, such as Romania, boosted by migration between 
these countries and Spain35. Similarly to Romania, this CRF has been found to be common among IDUs in 
Greece, where a large transmission network of CRF14_BG of recent origin (tMRCA = 2009) has been reported to 
affect more than 70 people, and which origin has been linked to strains from South-western Europe36.
We also detected two other transmission clusters of smaller size (n = 5 and n = 4) affecting Spanish-native 
MSMs of another highly pathogenic variant (CRF19_cpx), which we previously reported as the first evidence 
of expansion of this variant outside Cuba37. Despite the prevalence of these CRFs remaining low in the CV, the 
effective expansion of these highly pathogenic HIV variants, evidenced by the detection of transmission clusters, 
is of especial interest because it may hamper the control of the local HIV epidemic, especially among vulnerable 




error t-value Pr(>|t|) OR 2.50% 97.50%
14_BG:Age(>50) 3.59 1.64 2.188 0.028696 * 36.2 1.45 904
14_BG:RISK(HT) 2.39 1.43 1.674 0.094265 $ 11.0 0.664 181
02_AG:RISK(HT) 1.07 0.579 1.850 0.064773 $ 2.91 0.937 9.07
14_BG:RISK(UDI) 5.55 1.42 3.905 9.44E-05 *** 257.0 15.8 4160
14_BG:Eastern Europe 3.29 1.09 3.023 0.002502 ** 26.9 3.18 227
F:Eastern Europe 3.51 1.08 3.250 0.001155 ** 33.5 4.03 279
OTHERS: Eastern Europe 2.01 0.583 3.448 0.000566 *** 7.47 2.38 23.5
A1:Eastern Europe 2.78 0.795 3.493 0.000478 *** 16.1 3.38 76.3
F1:Africa and Middle East 3.50 1.05 3.353 0.000799 *** 33.3 4.29 258
G:Africa and Middle East 3.78 1.17 3.236 0.001218 ** 43.7 4.43 431
OTHERS: Africa and Middle East 2.77 0.554 5.009 5.48E-07 *** 16.0 5.41 47.4
A1:Africa and Middle East 1.92 0.993 1.932 0.053351 $ 6.81 0.973 47.7
02_AG:Africa and Middle East 3.76 0.580 6.478 9.28E-11 *** 42.9 13.8 134
14_BG:Latin America 2.71 1.38 1.955 0.050547 $ 15.0 0.994 225
OTHERS:Latin America 1.19 0.352 3.391 0.000696 ** 3.30 1.66 6.58
14_BG:ClusterLARGE 3.61 0.955 3.776 0.000159 *** 36.9 5.67 240
Table 3. Results of the multinomial analysis (only significant associations between each HIV variant and 
the categories compared at each variable are shown). ***P < 0.001; **0001 < P < 0.01; *0.01 < P < 0.05; 
$0.05 < P < 0.
Figure 4. Boxplots representing mean pairwise genetic distances (s/s) between individuals within transmission 
clusters of different sizes, as estimated with the TN93 + GAMMA (4 CAT) model. Green and red bars represent 
the minimum and maximum pairwise distances, respectively, between a pair of individuals from a given cluster 
size.
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The significant association between non-B variants and immigrants reported in this work and in previous 
molecular epidemiology analyses of HIV-1 in Madrid, Spain23, 29, as well as the aforementioned examples of emer-
gence of CRFs associated with migratory waves, suggest that high migration and tourism rates in some Spanish 
regions may contribute to the high genetic diversity of their HIV-1 epidemics. Thus, although our results suggest 
that non-B HIV groups are not well established in the local population, with only a few of them including patients 
of both Spanish and non-Spanish origin, this situation could change soon without intensified HIV prevention 
campaigns focused on vulnerable groups, including migrants, IDUs and MSM.
Although the large number of sequences for which no epidemiological information was available could be a 
potential limitation of our study, the results reported are representative of the sampled population and represent 
one of the most comprehensive analysis of the HIV pandemics in Spain22, 23, 29, 38.
We have found a significant, negative correlation between tree height and evolutionary rate estimates obtained 
when comparing the 12 largest clusters. Several publications have addressed this time-dependency on the evolu-
tionary rate (TDRP), that is, virus lineages estimated to have a recent origin yield higher estimated evolutionary 
rates than older viruses39–41. In our study the most plausible explanation for this phenomenon is the overestima-
tion of evolutionary rates in the most recent clusters, caused by the presence of deleterious mutations over which 
purifying selection has not had time to act. This phenomenon might be potentiated by the bottlenecks that occur 
at viral transmission, which might originate a transient accumulation of deleterious mutations. Consequently, 
these results suggest that TDRP is an important factor to consider in molecular epidemiology, even when datasets 
are obtained from the same population and at short timescales (in this case 10 years, from 2004 to 2014).
It is also important to mention that many works on the molecular epidemiology of HIV-1 remove 
resistance-associated positions from the analysis, in order to prevent spurious clustering by convergent evolution. 
In our analyses, we did not remove those positions because their impact on the detection of transmission clusters 
has been demonstrated to be irrelevant42. Furthermore, a great majority of our sequences were known to derive 
from treatment-naïve patients (only 66 patients were known to have been treated).
Additionally, although the identification or detection of transmission clusters is commonly based only on 
phylogenetic cluster support, it is also often based on criteria that combine phylogenetic support, usually high 
bootstrap values, with genetic distance (GD) thresholds43. In this work, we did not consider any GD threshold 
value as criterion to define transmission clusters. This is because the rationale for genetic distance cut-offs is rarely 
provided, with very different thresholds being reported in the literature44, and larger GD values are expected for 
older transmission events. In this way, choosing distance-based thresholds can lead to underestimating transmis-
sion clusters, especially those that span long time periods43, as it is the case of our dataset. Nevertheless, a great 
majority of GDs estimated from the pairwise comparisons performed here were lower than 0.045 s/s. Thus, almost 
all the transmission clusters reported here would be characterized by both high phylogenetic support and low GD.
In conclusion, our results provide evidence that the HIV-1 epidemic in the CV is dominated by subtype B, 
especially among local MSMs. Although there was an important number of non-B cases, they occurred mostly 
among immigrants. This suggests that non-B infections are not well established in the local population. However, 
the detection of transmission clusters of non-B variants associated to a higher pathogenicity and affecting Spanish 
patients, urges to increase efforts on HIV testing and prevention campaigns to prevent their further expansion.
Materials and Methods
Dataset. A total of 1804 PR/RT sequences were obtained from newly HIV diagnosed people at six different 
hospitals and two HIV counselling and testing centres (CIPS) from the three provinces in the CV between 2004 
and 2014. The sequences comprised the complete PR and the first 1005 nucleotides (335 amino acids) of the RT 
(1302 nt in total), and were obtained and subtyped as detailed in Patiño-Galindo et al.25.
Detection of local transmission clusters. Detection of transmission clusters, was performed following 
the same two-step procedure detailed in Patiño-Galindo et al.25 Briefly, in the first step, we obtained independ-
ent phylogenetic trees for each HIV-1 subtype and CRF detected, which included reference sequences retrieved 
from the Los Alamos HIV database spanning the analysed PR/RT region (n = 1787 subtype B, 2097 A1, 720 F1, 
854 G + CRF14_BG and 2157 CRF02_AG, as well as 5720 sequences from all the HIV-1 subtypes/CRFs that 
were rare in the CV dataset). The initial trees were reconstructed with FastTree 2.1 in order to detect potential 
transmission clusters, defined as clades with SH-like support ≥0.70, and containing ≥90% sequences from the 
CV dataset17.
In the second step, these potential clusters were confirmed with ML phylogenies obtained with PhyML 3.045 in 
which the following additional reference sequences were included: (i) the 10 sequences with the highest similarity 
to each CV sequence from the potential clusters, as retrieved with a BLASTN search at the NCBI server (https://
blast.ncbi.nlm.nih.gov/Blast.cgi); (ii) 854 subtype B, 77 A1, 74 F1, 173 G + CRF14_BG, 101 CRF02_AG as well 
as 482 reference sequences from the other HIV-1 subtypes/CRFs. Only those potential clusters which contained 
more than 90% of sequences from the CV and grouped in the ML tree with aLRT support ≥0.98 were considered 
as confirmed. Clusters were then classified depending on the major risk of transmission (≥50%) for the corre-
sponding patients from the CV.
Dated phylogenies. Dated phylogenies of large transmission clusters (those containing at least 10 patients 
from the CV46) were obtained with BEAST v1.8.147, similarly as in Patiño-Galindo et al.25. In those clusters with 
low root-to-tip divergence vs sampling date correlation (R < 0.4), a log-normal prior (median = 0.0025 per site 
and year, s/s/y, 95% HPD upper limit = 0.0035 s/s/y)17 was placed on the ucld.mean parameter.
Statistical analyses. A multinomial logistic regression analysis was performed in order to identify the main 
predictors of HIV-1 subtype/CRF group distribution, considering relevant epidemiologic variables: country of 
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origin, sex, risk group, collection date, age and clustering status. Due to the lack of epidemiological data for many 
sequences from the dataset, only 906 of the 1804 sequences were included in this analysis. Seven groups of differ-
ent HIV-1 subtypes and CRFs were used: A1 (n = 14), B (n = 752), F1 (n = 13), G (n = 11), 02_AG (n = 42) and 
14_BG (n = 15). All HIV-1 variants with fewer than 10 patients sampled were pooled as “Other variants” (n = 59). 
Prior to the multinomial analysis, univariate analyses (Fisher’s Exact Tests) were performed for the aforemen-
tioned variables, in order to exclude from the multinomial analysis those with non-significant p-values. Only 
the variable “collection date” (p-value > 0.70) was excluded. In the multinomial analysis, the most representative 
category of each variable was used as “baseline category” (Subtype B, Spaniard, male, MSM, age between 21 and 
29 years and not clustering; Supplementary Table S4). All the statistical analyses were performed using R48. The 
mlogit R package49 was used for the multinomial analysis.
Estimation of pairwise genetic distances. Pairwise genetic distances (GD) between individuals within 
transmission clusters were estimated, as substitutions per site (s/s), with the TN93 + Γ(4CAT) model, using Perl 
and R scripts (available upon request) dependent on the ape R package50.
Sequence information. GenBank accession numbers for the CV sequences used in this study are 
HF567872-HF567912 and MF403205–MF404967.
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